Overview

A Study to Investigate the Effects of Daridorexant on Nighttime Breathing in Patients With Shallow or Paused Breath During Sleep

Status:
Not yet recruiting

Trial end date:
2023-03-02

Target enrollment:

Participant gender:

Summary

A study on the effects of daridorexant on nighttime respiratory function in patients with severe obstructive sleep apnea (OSA).

Phase:

Phase 1

Details

Lead Sponsor:

Idorsia Pharmaceuticals Ltd.